This uncertainty reflects the ethical and practical challenges of conducting pregnancy studies with investigational medications
Repeated injections into the same site risk lipodystrophy, scarring, and variable absorption
Healthy lifestyle habits and your doctors ongoing support can help offset this
The FDA currently approves semaglutide for weight management in adults with a body mass index (BMI) of 30 or greater (classified as obesity), or a BMI of 27 or greater with at least one weight-related health condition, such as hypertension, type 2 diabetes, or high cholesterol
Grimm M, Han J, Weaver C, Griffin P, Schulteis CT, Dong H, Malloy J (2013) Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials